Pancreatic Cancer Research

ResearcherUniversity of MünsterActive in the last 2 years

Albrecht Schwab

Matched on ORCID iD 0000-0002-9280-2099; OpenAlex author ID A5110292114. Sources: OpenAlex.

Their work

Papers
9 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
38
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: 1 paper · 2020: 2 papers · 2021: 1 paper · 2022: none · 2023: 3 papers · 2024: none · 2025: none · 2026: 1 paper

Papers 9

  1. pH-Dependent Microenvironmental Ionic Signaling in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1111/apha.70183↗
  2. Acid-base homeostasis orchestrated by NHE1 defines the pancreatic stellate cell phenotype in pancreatic cancer. Last author DOI 10.1172/jci.insight.170928↗
  3. Acidic Growth Conditions Promote Epithelial-to-Mesenchymal Transition to Select More Aggressive PDAC Cell Phenotypes In Vitro. Co-author DOI 10.3390/cancers15092572↗
  4. TRPV6 Channel Is Involved in Pancreatic Ductal Adenocarcinoma Aggressiveness and Resistance to Chemotherapeutics. Co-author DOI 10.3390/cancers15245769↗
  5. Role of the TRP Channels in Pancreatic Ductal Adenocarcinoma Development and Progression. Co-author DOI 10.3390/cells10051021↗
  6. The A818-6 system as an in-vitro model for studying the role of the transportome in pancreatic cancer. Co-author DOI 10.1186/s12885-020-06773-w↗
  7. Ion Channels Orchestrate Pancreatic Ductal Adenocarcinoma Progression and Therapy. Last author DOI 10.3389/fphar.2020.586599↗
  8. The Activity of Kv 11.1 Potassium Channel Modulates F-Actin Organization During Cell Migration of Pancreatic Ductal Adenocarcinoma Cells. Co-author DOI 10.3390/cancers11020135↗
  9. Alternating pH landscapes shape epithelial cancer initiation and progression: Focus on pancreatic cancer. Co-author DOI 10.1002/bies.201600253↗

Closest collaborators

The 25 strongest of 38 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Natalia B. Prevarskaya · 4 shared papers, 2021–2026 · strength 0.71
  2. Zoltán Pethő · 3 shared papers, 2023–2026 · strength 0.52
  3. Annarosa Arcangeli · 3 shared papers, 2019–2026 · strength 0.40
  4. Gonçalo Mesquita · 2 shared papers, 2021–2023 · strength 0.36
  5. V’yacheslav Lehen’kyi · 2 shared papers, 2021–2023 · strength 0.36
  6. Tiago M. A. Carvalho · 2 shared papers, 2023–2026 · strength 0.34
  7. Stephan J. Reshkin · 2 shared papers, 2023–2026 · strength 0.34
  8. Rosa Angela Cardone · 2 shared papers, 2023–2026 · strength 0.34
  9. Madelaine Magalì Audero · 2 shared papers, 2023–2026 · strength 0.34
  10. Alessandra Fiorio · 2 shared papers, 2023–2026 · strength 0.34
  11. Verena Hofschröer · 2 shared papers, 2020–2026 · strength 0.31
  12. Anna Trauzold · 2 shared papers, 2020–2026 · strength 0.31
  13. Frauke Alves · 2 shared papers, 2017–2026 · strength 0.28
  14. Ivana Novak · 2 shared papers, 2017–2026 · strength 0.28
  15. Luis A. Pardo · 2 shared papers, 2017–2026 · strength 0.28
  16. Stine F. Pedersen · 2 shared papers, 2017–2026 · strength 0.28
  17. Pawel Swietach · 1 shared paper, 2026 · strength 0.19
  18. Sofie Hagelund · 1 shared paper, 2026 · strength 0.19
  19. Laura Mezzanotte · 1 shared paper, 2026 · strength 0.19
  20. Torsten Hechler · 1 shared paper, 2026 · strength 0.19
  21. Julie Schnipper · 1 shared paper, 2026 · strength 0.19
  22. Wiktoria Błaszczak · 1 shared paper, 2026 · strength 0.19
  23. Ganga Deshar · 1 shared paper, 2026 · strength 0.19
  24. Renata Ialchina · 1 shared paper, 2026 · strength 0.19
  25. Roisin McMorrow · 1 shared paper, 2026 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.